Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

Anti-hyperlipidemic Effect of Shiitake Mushroom Extract in Hyperlipidemic Rats Induced by Poloxamer-407

고지혈증 동물모델에서 표고버섯 추출물의 항고지혈증 효과

  • Received : 2013.03.17
  • Accepted : 2013.06.27
  • Published : 2013.08.25
Download PDF
⟨ Previous Next ⟩

Abstract

We attempted to determine the action target of Shiitake mushroom extract with a known anti-hyperlipidemic effect in poloxamer(P) 407-induced hyperlipidemia model. We investigated the anti-hyperlipidemic effects of the water extract from Shiitake mushroom on the progress of high fat diet for 4 weeks. Experimental rats were divided into 5 different experimental groups including an normal group (normal diet; n=10), control group (hyperlipidemia; n=10), Experimental group I (hyperlipidemic rats treated with Shiitake mushroom extract (100 mg/kg, PO), n=10), Experimental group II (hyperlipidemic rats treated with Shiitake mushroom extract (300 mg/kg, PO), n=10), and Experimental group III (hyperlipidemic rats treated with Shiitake mushroom extract (500 mg/kg, PO), n=10). It is to analysis changes in body weight, visceral fat weight, blood lipid profiles, HMG-CoA reductase and histological findings. Body weight and epididymal fat weight was not significantly change in experimental groups (p>0.05). The level of total cholesterol, TG, arthrogenic index, and HMG-CoA reductase were significantly lower in experimental groups than control group (p<0.05). These results suggested that the Shiitake mushroom extract administration may act by inhibitory the release of cholesterol related factors and HMG-CoA from the hepatocyte without liver and kidney cell damage in hyperlipidemia rats.

Keywords

References

  1. Liu, Z.L., Liu, J.P., Zhang, A.L., Wu, Q., Ruan, Y., Lewith, G., Visconte, D. Chinese herbal medicines for hyper cholesterolemia. Cochrane Database Syst Rev. 6(7):CD008305, 2011.
  2. Ford, E.S., Giles, W.H., Dietz, W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 287(3):356-359, 2002. https://doi.org/10.1001/jama.287.3.356
  3. Alexander, C.M., Landsman, P.B., Teutsch, SM, NHANES III, NCEP. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES m participants age 50 years and older. Diabetes. 52(5):1210-1214, 2003. https://doi.org/10.2337/diabetes.52.5.1210
  4. Lloyd-Jones, D., Adams, R., Camethon, M., De, S.G., Ferguson, T.B., Flegal, K., Ford, E., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S., Ho, M., Howard, V.Kissela, B., Kittner, S., Lackland, D., Lisabeth,L., Marelli, A., McDermott, M., Meigs J., Mozaffarian, D., Nichol, G., O'Donnell, C., Roger, V., Rosamond, W., Sacco, R. Sorlie, P., Stafford,R., Steinberger, J., Thom, T., Wasserthiel- Smoller, S., Wong, N. Wylie-Rosett, J., Hong, Y. Heart disease and stroke statistics 2009 update: a report from the American Heart Association Statistics Committee and Stroke statistics Subcommittee. Circulation, 119(3):21-181, 2009. https://doi.org/10.1161/CIRCULATIONAHA.108.191261
  5. National cholesterol education program (NCEP) expert panel on detection, Evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 106(25): 3143-3421, 2002.
  6. Zhao, Y., Ye, D., Wang, J., Calpe-Berdiel, L., Azzis, S.B., Van Berkel, T.J., Van Eck, M. Stage-specific remodeling of atherosclerotic lesions upon cholesterol lowering in LDL receptor knockout mice. Am J Pathol. 179(3):1522-1532, 2011. https://doi.org/10.1016/j.ajpath.2011.05.020
  7. Hong, K.H., Jang, K.H., Lee, J.C. Kim, S.H. Kim, M.K., Lee, I.Y. Kim, S.M. Lim, Y.H., Kang, S.A. Bacterial p-glucan exhibits potent hypoglycemic activity via decreased of serum lipids and adiposity, and increase of UCP mRNA expression. J Microbiol Biotechnol. 15(4):823-830, 2005.
  8. Catapano, A.L., Catapano, L. Global cardiovascular risk: the role of plasma lipids. High Blood Press Cardiovasc Prev. 12(3):125-133, 2005.
  9. Deepa, P.R., Varalakshmi, P. Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats. Clinica Chimica Acta. 355(1-2):119-130, 2005. https://doi.org/10.1016/j.cccn.2004.12.007
  10. Havel, R.J. The formation of LDL: mechanisms and regulation. J Lipid Res. 25(13):1570-1576, 1984.
  11. Vega, G.L., Grundy, S.M. Mechanisms of primary hypercholesterolemia in humans. Am Heart J. 113(2):493-502, 1987. https://doi.org/10.1016/0002-8703(87)90620-X
  12. Rodwell, V.W., Nordstrom, J.L., Mitschelen, J.J. Regulation of HMG CoA reductase. Adv Lipid Res. 14: 1-74, 1976.
  13. Goedeke, L., Fernandez Hernando, C. Regulation of cholesterol homeostasis. Cell Mol Life Sci. 69(6):915-930, 2012. https://doi.org/10.1007/s00018-011-0857-5
  14. Hopkins, P.N. Familial hypercholesterolemia-improving treatment and meeting guidelines. Int J Cardiol, 89(1):13-23, 2003. https://doi.org/10.1016/S0167-5273(02)00420-5
  15. Garg, A., Simha, V. Update on dyslipidemia. J Clin Endocrinol Metab, 92: 1581-1589, 2007. https://doi.org/10.1210/jc.2007-0275
  16. 전국한의과대학심계 내과학교실. 심계내과학. 서울, 서원당, pp 67-81; 212, 2002.
  17. 鄭遇悅, 安圭錫. 韓方臨床病理學. 서울, 永林社, p 545, 1998.
  18. 동의보감 탕액편․침구편․색인. 동의문헌연구실 편역, 서울, 법인문화사, 2005.
  19. Okuno, K., Uno, K. Efficacy of orally administered Lentinula edodes mycelia extract for advanced gastrointestinal cancer patients undergoing cancer chemotherapy: a pilot study. Asian Pac J Cancer Prev. 12(7):1671-1674, 2011.
  20. Zheng, R., Jie, S., Hanchuan, D., Moucheng, W. Characterization and immunomodulating activities of polysaccharide from Lentinus edodes. Int Immunopharmacol. 5(5):811-820, 2005. https://doi.org/10.1016/j.intimp.2004.11.011
  21. Jung, B.G., Lee, J.A., Lee, B.J. Immunoprophylactic effects of shiitake mushroom (Lentinula edodes) against Bordetella bronchisepticain mice. J Microbiol. 50(6):1003-1008, 2012. https://doi.org/10.1007/s12275-012-2365-1
  22. Johnston, T.P., Palmer, W.K. Mechanism of poloxamer 407-induced hyper triglyceridemia in the rat. Biochem Pharmacol. 46(6):1037-1042, 1993. https://doi.org/10.1016/0006-2952(93)90668-M
  23. Subramanian, S., Chait, A. Hypertriglyceridemia secondary to obesity and diabetes. Biochim Biophys Acta. 1821(5):819-825, 2012. https://doi.org/10.1016/j.bbalip.2011.10.003
  24. Deepa, P.R., Varalakshmi, P. Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats. Clin Chim Acta. 355(1-2):119-130, 2005. https://doi.org/10.1016/j.cccn.2004.12.007
  25. Palmer, W.K., Emeson, E.E., Johnston,T.P. The poloxamer 407-induced hyperlipidemic atherogenic animal model. Med Sci Sports Exerc. 29(11):1416-1421, 1997. https://doi.org/10.1097/00005768-199711000-00005
  26. Bisen, P.S., Baghel, R.K., Sanodiya,B.S., Thakur, G.S., Prasad, G.B. Lentinus edodes: a macrofungus with pharmacological activities. Curr Med Chem. 17(22): 2419-2430, 2010. https://doi.org/10.2174/092986710791698495
  27. Park, S.Y., Bae, I.Y., Lee, S., Lee, H.G. Physicochemical and hypocholesterolemic characterization of oxidized oat beta glucan. J Agric Food Chem. 57(2):439-443, 2009. https://doi.org/10.1021/jf802811b
  28. Agah Heris, M., Alipour, A., Janbozorgi, M., Hajihosseini, R., Shaghaghi, F., Golchin, N., Nouhi, S. Lipid profile improvement after four group psychological interventions in combination to nutritional and physical activity instructing among overweight and obese individuals. Iran J Public Health. 42(1):86-95, 2013.
  29. Teng, C.M., Kuo, S.C., Ko, F.N., Lee, J.C., Lee, L.G., Chen, S.C., Huang, T.F. Antiplatelet actions of panaxynol and ginsenosides isolated from ginseng. Biochim Biophys Acta. 990: 315-320, 1989. https://doi.org/10.1016/S0304-4165(89)80051-0
  30. Joo, I.W., Ryu, J.H., Oh, H.J. The influence of Sam-Chil-Geun (Panax notoginseng) on the serum lipid levels and inflammations of rats with hyperlipidemia induced by poloxamer 407. Yonsei Med J. 51(4):504-510, 2010. https://doi.org/10.3349/ymj.2010.51.4.504
  31. Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362: 801-809, 1993. https://doi.org/10.1038/362801a0
  32. Enman, J., Rova, U., Berglund, K.A. Quantification of the bioactive compound eritadenine in selected strains of shiitake mushroom (Lentinus edodes). J Agric Food Chem. 55(4):1177-1180, 2007. https://doi.org/10.1021/jf062559+
  33. Shimada, Y., Morita, T., Sugiyama, K. Eritadenine-induced alterations of plasma lipoprotein lipid concentrations and phosphatidyl choline molecular species profile in rats fed cholesterol-free and cholesterol enriched diets. Biosci Biotechnol Biochem. 67(5):996-1006, 2003. https://doi.org/10.1271/bbb.67.996
  34. Kostner, G.M. Pharmacology of HMG-CoA reductase inhibitors (statins). Wien Med Wochenschr. 149(5-6): 120-124, 1999.
  35. Bocan, T.M., Mueller, S.B., Brown, E.Q., Lee, P., Bocan, M.J., Rea, T., Pape, M.E. HMG CoA reductase and ACAT inhibitors act synergistically to lower plasmacholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit. Atherosclerosis. 139(1):21-30, 1998.
  36. Porter, J.A., Carter, B.L., Johnson,T.P., Palmer, W.K. Effects of pravastatin on plasma lipid concentrations in poloxamer 407 induced hyperlipidemic rats. Pharmacotherapy. 15(1):92-98, 1995.
  37. Qu, L., Xin, H., Zheng, G., Su, Y., Ling, C. Hepato protective activity of the total saponins from actinidia valvata dunn root against carbon tetrachloride-induced liver damage in mice. Evid Based Complement Altemat Med. 216061, 2012.
  38. Ma, X., Li, Z. Pathogenesis of nonalcoholic steatohepatitis (NASH). Chin J Dig Dis. 7(1):7-11, 2006. https://doi.org/10.1111/j.1443-9573.2006.00237.x
  39. Zou, Y., Li, J., Lu, C., Wang, J., Ge, J., Huang, Y., Zhang, L., Wang, Y. High-fat emulsion induced rat model of nonalcoholic steatohepatitis. Life Sci. 79(11):1100-1107, 2006. https://doi.org/10.1016/j.lfs.2006.03.021